Mitigation of the septal lesion syndrome by pre-lesion chronic treatment with haloperidol.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology; D012688:Septum Pellucidum / Q000502:physiology*
D011954:Receptors, Dopamine; D006220:Haloperidol; D001058:Apomorphine